Call Options

28 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$10.58 - $17.9 $422,142 - $714,210
39,900 Added 65.09%
101,200 $1.1 Million
Q1 2024

May 07, 2024

SELL
$18.62 - $26.95 $1.78 Million - $2.58 Million
-95,800 Reduced 60.98%
61,300 $1.15 Million
Q4 2023

Feb 14, 2024

SELL
$17.1 - $22.26 $3.07 Million - $4 Million
-179,600 Reduced 53.34%
157,100 $3.4 Million
Q3 2023

Nov 14, 2023

BUY
$16.75 - $48.98 $3.01 Million - $8.8 Million
179,700 Added 114.46%
336,700 $6.93 Million
Q2 2023

Aug 11, 2023

SELL
$40.65 - $59.54 $1.48 Million - $2.16 Million
-36,300 Reduced 18.78%
157,000 $7.38 Million
Q1 2023

May 16, 2023

BUY
$37.27 - $46.57 $3.07 Million - $3.84 Million
82,500 Added 74.46%
193,300 $8.11 Million
Q4 2022

Feb 14, 2023

SELL
$32.2 - $43.61 $1.27 Million - $1.71 Million
-39,300 Reduced 26.18%
110,800 $4.23 Million
Q3 2022

Nov 14, 2022

BUY
$32.28 - $43.27 $1.51 Million - $2.03 Million
46,800 Added 45.3%
150,100 $5.88 Million
Q2 2022

Aug 15, 2022

BUY
$27.52 - $37.99 $1.38 Million - $1.91 Million
50,200 Added 94.54%
103,300 $3.34 Million
Q1 2022

May 16, 2022

SELL
$30.71 - $45.71 $1.94 Million - $2.89 Million
-63,300 Reduced 54.38%
53,100 $1.76 Million
Q4 2021

Feb 14, 2022

BUY
$37.06 - $47.11 $1.46 Million - $1.85 Million
39,300 Added 50.97%
116,400 $4.95 Million
Q3 2021

Nov 15, 2021

SELL
$40.26 - $57.37 $2.88 Million - $4.11 Million
-71,600 Reduced 48.15%
77,100 $3.42 Million
Q2 2021

Aug 11, 2021

BUY
$54.88 - $79.29 $2.79 Million - $4.04 Million
50,900 Added 52.04%
148,700 $8.45 Million
Q1 2021

May 17, 2021

SELL
$70.65 - $96.76 $3.17 Million - $4.34 Million
-44,900 Reduced 31.46%
97,800 $7.32 Million
Q4 2020

Feb 16, 2021

SELL
$58.41 - $89.06 $3.09 Million - $4.71 Million
-52,900 Reduced 27.04%
142,700 $12.3 Million
Q3 2020

Nov 16, 2020

BUY
$41.13 - $62.45 $3.81 Million - $5.78 Million
92,600 Added 89.9%
195,600 $12 Million
Q2 2020

Aug 14, 2020

SELL
$25.95 - $43.15 $189,435 - $314,995
-7,300 Reduced 6.62%
103,000 $4.28 Million
Q1 2020

May 15, 2020

SELL
$26.15 - $77.24 $11.3 Million - $33.4 Million
-432,200 Reduced 79.67%
110,300 $3.17 Million
Q4 2019

Feb 14, 2020

BUY
$60.18 - $154.77 $19.7 Million - $50.7 Million
327,900 Added 152.8%
542,500 $39.2 Million
Q3 2019

Nov 14, 2019

BUY
$140.29 - $189.96 $7.49 Million - $10.1 Million
53,400 Added 33.13%
214,600 $30.1 Million
Q2 2019

Aug 14, 2019

SELL
$157.85 - $183.09 $1.28 Million - $1.48 Million
-8,100 Reduced 4.78%
161,200 $29.5 Million
Q1 2019

May 15, 2019

SELL
$89.33 - $163.65 $15.9 Million - $29.2 Million
-178,300 Reduced 51.29%
169,300 $26.9 Million
Q4 2018

Feb 14, 2019

BUY
$81.94 - $139.71 $15.9 Million - $27 Million
193,500 Added 125.57%
347,600 $33.3 Million
Q3 2018

Nov 14, 2018

BUY
$138.11 - $169.04 $580,062 - $709,968
4,200 Added 2.8%
154,100 $21.8 Million
Q2 2018

Aug 14, 2018

SELL
$140.36 - $175.76 $1.4 Million - $1.76 Million
-10,000 Reduced 6.25%
149,900 $23.5 Million
Q1 2018

May 15, 2018

SELL
$152.15 - $192.33 $16.7 Million - $21.1 Million
-109,800 Reduced 40.71%
159,900 $25.8 Million
Q4 2017

Feb 14, 2018

SELL
$60.72 - $167.34 $9.27 Million - $25.6 Million
-152,700 Reduced 36.15%
269,700 $44.4 Million
Q3 2017

Nov 14, 2017

BUY
$61.4 - $88.52 $25.9 Million - $37.4 Million
422,400
422,400 $26.3 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.